Equestrian Sports New Zealand (ESNZ) has received notification from the International Equestrian Federation (FEI) that the B blood sample taken from Clifton Promise at the Burghley International Horse Trials has tested positive for the banned substance Reserpine. Clifton Promise, owned by Frances Stead, was ridden to victory at the event by Jock Paget in early September.
Paget is now required to submit written documentation to the FEI explaining the presence of the banned substance in Clifton Promise’s bloodstream. He is confident of providing the FEI with a comprehensive explanation which will be considered at a hearing of the FEI Tribunal.
Paget says that while the B sample result is disappointing, it was expected given the blood in the B sample was taken at the same time as the A sample.
“ I will continue to work closely with my team to provide a full explanation to the FEI.”
ESNZ was notified of the positive test from the A sample on 14th October, and since then both the rider and horse have been provisionally suspended from FEI and national competitions. In keeping with ESNZ’s own Clean Sport policy and its full support of the FEI’s Clean Sport programme, Paget has been stood down from any official ESNZ activity while the legal process is underway.
Jim Ellis, ESNZ Chief Executive, says Paget is understanding and fully supportive of ESNZ’s position as the FEI judicial process takes its course.
“ESNZ is confident that he will provide a full and persuasive explanation to the FEI.”
MEDIA STATEMENT FROM ESNZ
